In support of enhancing supply chain integrity and aligning with internationally recognised standards and practices, the Pharmacy and Poisons Board of Hong Kong (the “Board”) endorsed the proposal to implement Good Distribution Practice (“GDP”) in Hong Kong by adopting the Pharmaceutical Inspection Co-operation Scheme Guide to Good Distribution Practice. The proposal will be implemented through the imposition of additional application requirements or licensing conditions on manufacturers and wholesale dealers, tentatively start off with new applicants in Q3 2026 as licensing requirements and extend to relevant existing licensees in Q3 2028.
In this connection, the following draft documents for implementation of GDP have been prepared for inviting comments and views from the public.
Guidance Documents (to be uploaded):
- Guide to Good Distribution Practice for Pharmaceutical Products (“GDP Guide”)
- Guidance for Industry: Guide to Good Distribution Practice for Pharmaceutical Products (“Guidance for Industry”)
- Revised Code of Practice for Holder of Wholesale Dealer Licence (“WDL COP”)
If the public have any comments on the above draft documents, please send them to the Drug Office of the Department of Health on or before 31 May 2026 by any of the following means:
Mail: |
Drug Office
Department of Health
Room 2001-2002,
20/F, Dah Sing Financial Centre,
248 Queen's Road East,
Wan Chai, Hong Kong
|
Fax: |
3107 0221 |
Email: |
|
Home > What's New > Consultation on the Implementation of Good Distribution Practice (GDP) for Pharmaceutical Products